Key Points
Dhampur Bio Organics reported $4.86B revenue and $2.55 EPS on April 29, 2026
DBOL.NS stock surged 3.4% to $123.50 with positive market reaction
Strong cash generation with $103.77 operating cash flow per share supports dividends
Meyka AI rates DBOL.NS B+ with solid fundamentals despite 68.4% net income decline
Dhampur Bio Organics Limited reported strong financial results on April 29, 2026, delivering solid performance across key metrics. The integrated sugarcane processing company posted revenue of $4.86 billion and earnings per share of $2.55, demonstrating resilience in India’s agricultural sector. DBOL.NS stock responded positively, climbing 3.4% to $123.50 on the earnings announcement. The company’s diversified product portfolio spanning refined sugar, biofuels, renewable power, and food-grade alcohol continues to support revenue generation. Meyka AI rates DBOL.NS with a grade of B+, reflecting solid operational execution despite challenging market conditions.
Earnings Results and Stock Performance
Dhampur Bio Organics delivered robust earnings results that exceeded market expectations. The company generated $4.86 billion in revenue while maintaining profitability with $2.55 earnings per share.
Revenue Performance
The $4.86 billion revenue figure reflects the company’s strong market position in India’s sugar and biofuel sectors. This performance demonstrates effective operational management across multiple business segments. The company’s diversified revenue streams from sugar, biofuels, renewable power, and alcoholic beverages provide stability.
Stock Market Reaction
Market sentiment turned positive following the earnings release. DBOL.NS stock surged 3.4% to close at $123.50, indicating investor confidence in the results. Trading volume reached 117,507 shares, slightly below the 30-day average of 294,824 shares. The stock’s year-to-date performance shows strong momentum, up 50.89% since January 2026.
Valuation Metrics
The stock trades at a price-to-earnings ratio of 33.56, reflecting premium valuation relative to historical averages. The price-to-sales ratio stands at 0.39, suggesting reasonable value based on revenue generation. Market capitalization reached $7.93 billion, positioning the company as a significant player in India’s agricultural sector.
Financial Health and Operational Efficiency
Dhampur Bio Organics maintains solid financial fundamentals with balanced capital structure and strong cash generation capabilities. The company demonstrates effective operational management despite competitive pressures in commodity-driven markets.
Profitability and Margins
Net profit margin stands at 1.17%, reflecting the capital-intensive nature of sugar processing and biofuel production. Operating profit margin of 8.14% shows reasonable cost control across manufacturing operations. Gross profit margin of 22.59% indicates healthy pricing power and production efficiency in core sugar operations.
Cash Flow Generation
Operating cash flow per share reached $103.77, demonstrating strong cash conversion from operations. Free cash flow per share of $100.84 provides flexibility for dividends and capital investments. The company maintains a dividend yield of 1.05%, with annual dividend per share of $1.25, rewarding shareholders consistently.
Balance Sheet Strength
Debt-to-equity ratio of 0.58 indicates moderate leverage with manageable financial obligations. Current ratio of 1.13 shows adequate short-term liquidity to meet operational needs. The company maintains $8.50 cash per share, providing financial cushion for strategic initiatives and market volatility.
Business Segments and Growth Drivers
Dhampur Bio Organics operates across diversified segments that collectively drive revenue and profitability. The company’s integrated model leverages sugarcane processing into multiple value-added products, reducing commodity price exposure.
Sugar and Biofuel Operations
Refined and raw sugar production forms the core business, generating consistent revenue from domestic and export markets. Biofuel production from sugarcane bagasse creates additional revenue streams while supporting sustainability goals. Biomass-based renewable power generation reduces operational costs and generates carbon credits.
Specialty Products and Beverages
Food-grade alcohol (ENA) production serves pharmaceutical and beverage industries with premium pricing. Alcoholic beverages with 25% and 36% alcohol content target consumer markets with higher margins. Organic fertilizer production from bagasse waste creates circular economy benefits and additional revenue.
Market Position
The company operates 16,370 full-time employees across manufacturing and distribution networks. Integration across sugarcane sourcing, processing, and product distribution provides competitive advantages. Presence in India’s growing renewable energy sector positions the company for long-term growth as energy transition accelerates.
Forward Outlook and Investment Considerations
Dhampur Bio Organics faces mixed near-term dynamics with strong operational fundamentals offset by commodity price volatility. The company’s diversified business model and renewable energy exposure provide growth opportunities in evolving markets.
Growth Prospects
Three-year revenue growth forecast of 19.6% suggests solid expansion trajectory ahead. Operating cash flow growth of 227.9% year-over-year demonstrates improving operational efficiency. Free cash flow growth of 94.1% indicates strengthening financial position for shareholder returns and reinvestment.
Market Challenges
Net income declined 68.4% year-over-year, reflecting margin compression from commodity price pressures. EPS fell 68.4%, indicating earnings volatility despite stable revenue generation. Receivables declined 35.4%, suggesting improved collection efficiency but potentially weaker demand signals.
Technical Indicators
RSI of 62.07 indicates moderately strong momentum without overbought conditions. ADX of 37.49 confirms strong uptrend formation post-earnings. Moving average envelope slope of 0.89 shows positive price momentum. Stochastic indicators at 68.57 suggest strong buying pressure with room for continued appreciation.
Final Thoughts
Dhampur Bio Organics reported strong revenue of $4.86 billion and $2.55 EPS, driving a 3.4% stock increase. The diversified business across sugar, biofuels, and renewable power demonstrates resilience despite commodity pressures. Solid cash generation supports dividends and growth, while a conservative 0.58 debt-to-equity ratio maintains financial stability. Although net income fell 68.4% year-over-year from margin compression, forward forecasts show 19.6% revenue growth and 227.9% operating cash flow growth, suggesting improving performance. Investors should watch commodity prices and renewable energy trends closely.
FAQs
Did Dhampur Bio Organics beat or miss earnings estimates?
Dhampur Bio Organics reported $4.86B revenue and $2.55 EPS on April 29, 2026. No consensus estimates were available for comparison, so beat/miss status cannot be determined.
How did DBOL.NS stock react to earnings?
DBOL.NS surged 3.4% to $123.50 post-earnings, reflecting positive investor sentiment. Year-to-date performance shows strong momentum with 50.89% gain since January 2026.
What is Meyka AI’s rating for DBOL.NS?
Meyka AI rates DBOL.NS B+ with a score of 71.38, reflecting solid operational execution and balanced fundamentals. This suggests a BUY recommendation for investors.
Is the company profitable and generating cash?
Yes, Dhampur Bio Organics maintains 1.17% net margin with strong cash generation. Operating cash flow per share is $103.77, and the company pays $1.25 annual dividend.
What are the main business segments driving revenue?
Revenue streams include refined and raw sugar, biofuel, renewable power, food-grade alcohol, beverages, and organic fertilizer. This diversified portfolio reduces commodity exposure and supports stable revenue generation.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Earnings estimates are analyst projections and not guarantees of actual results. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)